Kinga Sałat

Development of an in-vivo active reversible butyrylcholinesterase inhibitor

Urban Košak, Boris Brus, Damijan Knez et al. · Scientific Reports · 2016 · 159 citations · Full text

The Magic of Crystal Structure-Based Inhibitor Optimization: Development of a Butyrylcholinesterase Inhibitor with Picomolar Affinity and in Vivo Activity

Urban Košak, Boris Brus, Damijan Knez et al. · Journal of Medicinal Chemistry · 2017 · 151 citations · Full text

Combinatorial Chemistry, Scopolamine Model, Neurochemical Biomarkers +23

Antinociceptive activity of transient receptor potential channel TRPV1, TRPA1, and TRPM8 antagonists in neurogenic and neuropathic pain models in mice

Kinga Sałat, Barbara Filipek · Journal of Zhejiang University SCIENCE B · 2015 · 90 citations · Full text

Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor

Kinga Sałat, Agata Siwek, Gabriela Starowicz et al. · Neuropharmacology · 2015 · 75 citations · Full text

Psychoactive Drug, Psychiatry, Antidepressant-like Effects +10

Anticonvulsant active inhibitor of GABA transporter subtype 1, tiagabine, with activity in mouse models of anxiety, pain and depression

Kinga Sałat, Adrian Podkowa, Paula Kowalczyk et al. · Pharmacological Reports · 2014 · 68 citations · Full text

Anticonvulsant Active Inhibitor, Psychiatry, Medicine +11